Operating profit before deduction of amortization: Indaptus Therapeutics, Inc. (INDP)
Quarterly EBITDA demonstrates a real cash inflow, while the 0.00 value reflects the metric's balance. Patents for the IT platform utilizing bacteria create a powerful defensive moat, despite strict FDA oversight. Indaptus Therapeutics (INDP) management is focused on developing safe oncology treatment methods. Diversified manufacturing sites guarantee the stable, uninterrupted supply of rare biocomponents.
Indaptus Therapeutics, Inc. (INDP) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Indaptus Therapeutics|INDP - Long-Term Debt to Capital|Current Liabilities to Capital Indaptus Therapeutics Inc|INDP - Company Aggregate Debts|Debts to Net Assets Indaptus Therapeutics|INDP - Company Long-Term Debt|Company Short-Term Indebtedness Indaptus Therapeutics|Immediate Liquidity Ratio indaptusrx.com
- earnings and multiples data:
INDP - Net Profit|Projected Future Earnings Indaptus Therapeutics|INDP - Price to Earnings Ratio|Price to Expected Earnings Ratio indaptusrx.com|INDP - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Indaptus Therapeutics|INDP - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Indaptus Therapeutics|INDP - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months indaptusrx.com|INDP - Net earnings per share growth this year|Expected earnings per share trend next year Indaptus Therapeutics
Summary company analytics:INDP Indaptus Corp
Indaptus Therapeutics' development of an innovative immunoactivation platform for cancer therapy requires significant expenditures, making the monitoring of operating profit 0.00 critical for assessing the efficiency of the business model. This metric measures the actual cash flow from core operations before depreciation and taxes, allowing investors to compare asset growth rates with debt load through EBITDA analytics to protect capital from overvaluation.
Competitors of Indaptus Therapeutics (INDP)
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BioCryst Pharmaceuticals Inc - Operating profit EBITDA|Operating income before deduction of amortization Vera Corp VERA|Dianthus Therapeutics (DNTH) - Profit before payment of interest, taxes and amortization|Operating profit before amortization PHVS|ABCL (AbCellera Biologics Inc.) - Operating profit EBITDA|Operating profit before amortization TRML (Tourmaline Bio Inc)|Operating profit EBITDA PGEN|Operating profit EBITDA Pharming Corp (PHAR)|Profit before payment of interest, taxes and amortization Nektar Therapeutics NKTR|UPB (upstreambio.com) - Profit before deduction of interest, taxes, depreciation and amortization|ZBIO: Operating profit before deduction of amortization|Immunome Inc - Company profit before taxes, interest and amortization|GOSS (Gossamer Corp) - Operating profit before deduction of amortization|KalVista Corp (KALV) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Septerna Inc|pieris.com (PVLA) - Operating income before deduction of amortization|Operating profit before deduction of amortization SVRA (Savara)|RIGL (Rigel Pharma) - Income before deduction of interest, taxes and amortization|AnaptysBio Corp - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization ATXS (Astria Corp)|enGene Holdings Inc. - Operating profit EBITDA|Income before deduction of interest, taxes and amortization RAPT (RAPT Therapeutics Inc.)|JBIO: Operating profit EBITDA|Profit before interest, taxes and amortization Aclaris Therapeutics Inc. (ACRS)|Profit before payment of interest, taxes and amortization Kyverna|TLSA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA CABA|Operating profit EBITDA ventyxbio.com (VTYX)|Profit before payment of interest, taxes and amortization Theratechnologies THTX|AVTX (Avalo Therapeutics, Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|Eledon - Operating profit EBITDA|Profit before interest, taxes and amortization Agenus, Inc|CLYM (Climb Bio Inc) - Operating profit before deduction of amortization|Zura Bio Ltd (ZURA) - Operating profit EBITDA|Operating profit before deduction of amortization ATYR|ADAG (Adagene Corp) - Company profit before taxes, interest and amortization|Operating profit EBITDA IMA|Operating income before deduction of amortization shattucklabs.com|Operating profit EBITDA EQ (Equillium)|CNTB - Operating profit before deduction of amortization|IMUX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Atara Biotherapeutics ATRA|IFRX: Operating profit EBITDA|XFOR - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Adicet Bio Inc.|Operating profit before amortization CELU (Celularity Corp)|Operating profit EBITDA INMB|Barinthus Biotherapeutics PLC - Operating profit before amortization|Profit before payment of interest, taxes and amortization Kezar Life Sciences, Inc KZR|SABS (SAB Biotherapeutics Inc) - Profit before deduction of interest, taxes, depreciation and amortization|AKTX - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ENLV|QTTB: Operating profit EBITDA|GeoVax Labs - Income before deduction of interest, taxes and amortization|EDSA (Edesa) - Operating profit EBITDA|Operating profit EBITDA iBio Corporation|Profit before payment of interest, taxes and amortization Carisma Therapeutics (CARM)|XTLB (xtlbio.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Bolt Biotherapeutics, Inc. BOLT|HCWB - Operating profit before deduction of amortization|Aptevo - Operating profit EBITDA|AIM - Operating profit EBITDA|ADTX (aditxt.com) - Operating profit before deduction of amortization|gribio.com - Income before deduction of interest, taxes and amortization|XRTX (XORTX Therapeutics) - Operating profit EBITDA|Vyome Holdings Inc. (HIND) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Revelation Bio (REVB)|Operating profit before deduction of amortization BiondVax Pharmaceuticals SCNI|Profit before payment of interest, taxes and amortization CalciMedica CALI|AFMD - Operating profit before deduction of amortization|ALLK: Operating profit before deduction of amortization|HOOK - Operating profit EBITDA|igmbio.com (IGMS) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ITOS|OCEA (Ocean Biomedical, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization tcbiopharm.com TCBP|Operating profit EBITDA THRD
